Here’s whether Johnson & Johnson (JNJ) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+2.49% over 10 days); RSI 40 — healthy momentum range; strong 1-year return of +49.0%; 3-month momentum positive (+14.8%). Currently 5.3% off its 52-week high. Score: +7/7.
JNJ is in a confirmed uptrend, trading above both its 50-day ($251.31) and 200-day ($229.78) moving averages. An RSI of 40.3 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +49.0% compares to +20.4% for SPY (beat the market by 28.6%).
$10,000 invested 1 year ago→ $14,901 today
vs. S&P 500 (SPY) — same period beat market by 28.6%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($229.78)
✓Above 50-day MA ($251.31)
✓RSI(14) neutral zone (30–70) — currently 40.3
✓Positive return (+49.0%)
✓Within 10% of period high (−5.3%)
Period Range $260.35
$172.72$274.90
RSI (14) 40.3
0 · OversoldOverbought · 100
Key Metrics
Price$260.35
Period Return+49.0%
Period High$274.90
Period Low$172.72
Drawdown−5.3%
MA-50$251.31
MA-200$229.78
RSI (14)40.3
Avg Volume (30d)7.6M
vs. SPYbeat by 28.6%
Return Rank#301 of 1252
Trend Signals
Price is above the 200-day moving average ($229.78)
Price is above the 50-day moving average ($251.31)